

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA deamination (GO:0045006) | 7.67440492 |
| 2 | negative regulation of mast cell activation (GO:0033004) | 6.77314280 |
| 3 | cytidine catabolic process (GO:0006216) | 6.49748454 |
| 4 | cytidine deamination (GO:0009972) | 6.49748454 |
| 5 | cytidine metabolic process (GO:0046087) | 6.49748454 |
| 6 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 6.32456286 |
| 7 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.52829191 |
| 8 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.66001991 |
| 9 | T cell migration (GO:0072678) | 4.44206246 |
| 10 | lung lobe morphogenesis (GO:0060463) | 4.31618307 |
| 11 | regulation of DNA endoreduplication (GO:0032875) | 4.22935693 |
| 12 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 4.19772187 |
| 13 | rRNA catabolic process (GO:0016075) | 4.18432785 |
| 14 | T cell lineage commitment (GO:0002360) | 3.98120549 |
| 15 | respiratory tube development (GO:0030323) | 3.94555890 |
| 16 | signal peptide processing (GO:0006465) | 3.91034973 |
| 17 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.80249432 |
| 18 | NADH metabolic process (GO:0006734) | 3.76017168 |
| 19 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.72728933 |
| 20 | protein K6-linked ubiquitination (GO:0085020) | 3.69809717 |
| 21 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 3.68929043 |
| 22 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 3.68929043 |
| 23 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 3.68929043 |
| 24 | lung vasculature development (GO:0060426) | 3.68574435 |
| 25 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.66493386 |
| 26 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.66493386 |
| 27 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.66419478 |
| 28 | tricarboxylic acid cycle (GO:0006099) | 3.63892037 |
| 29 | nucleoside diphosphate catabolic process (GO:0009134) | 3.61943881 |
| 30 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 3.55209729 |
| 31 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 3.55209729 |
| 32 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.50836095 |
| 33 | DNA strand renaturation (GO:0000733) | 3.50237024 |
| 34 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.48161578 |
| 35 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.46499913 |
| 36 | DNA double-strand break processing (GO:0000729) | 3.45675079 |
| 37 | polarized epithelial cell differentiation (GO:0030859) | 3.44815371 |
| 38 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.39455764 |
| 39 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.38323286 |
| 40 | complement activation, classical pathway (GO:0006958) | 3.35683568 |
| 41 | oxaloacetate metabolic process (GO:0006107) | 3.34514051 |
| 42 | midgut development (GO:0007494) | 3.33808614 |
| 43 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.28571659 |
| 44 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.26149922 |
| 45 | immunoglobulin mediated immune response (GO:0016064) | 3.25532100 |
| 46 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.25130589 |
| 47 | ribonucleoprotein complex disassembly (GO:0032988) | 3.23871220 |
| 48 | B cell mediated immunity (GO:0019724) | 3.22366390 |
| 49 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.19915831 |
| 50 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.17966916 |
| 51 | rRNA methylation (GO:0031167) | 3.17940994 |
| 52 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 3.16077431 |
| 53 | negative regulation of B cell proliferation (GO:0030889) | 3.15582077 |
| 54 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.09437898 |
| 55 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 3.08308876 |
| 56 | NADH dehydrogenase complex assembly (GO:0010257) | 3.08308876 |
| 57 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 3.08308876 |
| 58 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.06595243 |
| 59 | negative regulation of ligase activity (GO:0051352) | 3.05059953 |
| 60 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.05059953 |
| 61 | rRNA modification (GO:0000154) | 3.03399013 |
| 62 | DNA demethylation (GO:0080111) | 3.03270661 |
| 63 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.02887013 |
| 64 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 3.01006692 |
| 65 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.00919983 |
| 66 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 2.99643342 |
| 67 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.95348913 |
| 68 | ATP synthesis coupled proton transport (GO:0015986) | 2.94699017 |
| 69 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.94699017 |
| 70 | establishment of apical/basal cell polarity (GO:0035089) | 2.92531868 |
| 71 | proteasome assembly (GO:0043248) | 2.91483424 |
| 72 | respiratory chain complex IV assembly (GO:0008535) | 2.91043710 |
| 73 | lymphocyte migration (GO:0072676) | 2.90932570 |
| 74 | replicative senescence (GO:0090399) | 2.89411893 |
| 75 | regulation of helicase activity (GO:0051095) | 2.88750524 |
| 76 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.87822040 |
| 77 | regulation of hypersensitivity (GO:0002883) | 2.86740618 |
| 78 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.86458421 |
| 79 | platelet dense granule organization (GO:0060155) | 2.85008829 |
| 80 | CENP-A containing nucleosome assembly (GO:0034080) | 2.84555674 |
| 81 | chromatin remodeling at centromere (GO:0031055) | 2.84068619 |
| 82 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.79928623 |
| 83 | formation of translation preinitiation complex (GO:0001731) | 2.79380359 |
| 84 | protein complex biogenesis (GO:0070271) | 2.78819480 |
| 85 | cardiac left ventricle morphogenesis (GO:0003214) | 2.78602788 |
| 86 | endocardial cushion development (GO:0003197) | 2.78517454 |
| 87 | DNA ligation (GO:0006266) | 2.76882708 |
| 88 | positive regulation of ligase activity (GO:0051351) | 2.75818344 |
| 89 | chaperone-mediated protein transport (GO:0072321) | 2.73941292 |
| 90 | positive regulation of cell cycle arrest (GO:0071158) | 2.72328252 |
| 91 | establishment of epithelial cell polarity (GO:0090162) | 2.72011110 |
| 92 | establishment of chromosome localization (GO:0051303) | 2.70717226 |
| 93 | negative regulation of viral release from host cell (GO:1902187) | 2.68528144 |
| 94 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.68418537 |
| 95 | regulation of T-helper cell differentiation (GO:0045622) | 2.68103773 |
| 96 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.67900676 |
| 97 | mitotic nuclear envelope disassembly (GO:0007077) | 2.67405045 |
| 98 | positive regulation of humoral immune response (GO:0002922) | 2.67377200 |
| 99 | ribosomal small subunit assembly (GO:0000028) | 2.66637673 |
| 100 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.66345458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 6.55688958 |
| 2 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 4.33582990 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.27335374 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.16270028 |
| 5 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.03625926 |
| 6 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.01811182 |
| 7 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.64832693 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.33059553 |
| 9 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.29810990 |
| 10 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.21393830 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.18558480 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.90210232 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.87009563 |
| 14 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.71144091 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.50094111 |
| 16 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.44087959 |
| 17 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.43546342 |
| 18 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.42444679 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.36810979 |
| 20 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.33308174 |
| 21 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.29962501 |
| 22 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.21680584 |
| 23 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.19035495 |
| 24 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.12715282 |
| 25 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.97463949 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.95144338 |
| 27 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.91773167 |
| 28 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.89878209 |
| 29 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.85741501 |
| 30 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.83995479 |
| 31 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.82011104 |
| 32 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.79750389 |
| 33 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.79503969 |
| 34 | GATA1_22025678_ChIP-Seq_K562_Human | 1.76375315 |
| 35 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.74062008 |
| 36 | VDR_22108803_ChIP-Seq_LS180_Human | 1.69010681 |
| 37 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.62951821 |
| 38 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62949820 |
| 39 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.60383526 |
| 40 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.57378295 |
| 41 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.56596872 |
| 42 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.55527992 |
| 43 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.55344996 |
| 44 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.55066534 |
| 45 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.53011903 |
| 46 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.50365007 |
| 47 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.48820078 |
| 48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.48089310 |
| 49 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.46750400 |
| 50 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.40063082 |
| 51 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.36155512 |
| 52 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.34497488 |
| 53 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.34167707 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.32522978 |
| 55 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.31978294 |
| 56 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.31176901 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30287529 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.24499272 |
| 59 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.24261539 |
| 60 | MYB_26560356_Chip-Seq_TH2_Human | 1.23385791 |
| 61 | EWS_26573619_Chip-Seq_HEK293_Human | 1.17844669 |
| 62 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.17532685 |
| 63 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.14016134 |
| 64 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.10637509 |
| 65 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.09137034 |
| 66 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.03374130 |
| 67 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02498295 |
| 68 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01592446 |
| 69 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.01132380 |
| 70 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.00569488 |
| 71 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.96152905 |
| 72 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.95908503 |
| 73 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.95135629 |
| 74 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.94059437 |
| 75 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.93170007 |
| 76 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.92486685 |
| 77 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.92259241 |
| 78 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.92245458 |
| 79 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.92125519 |
| 80 | MYC_22102868_ChIP-Seq_BL_Human | 0.91790179 |
| 81 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91261310 |
| 82 | MYB_26560356_Chip-Seq_TH1_Human | 0.91006489 |
| 83 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.89769965 |
| 84 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.89769965 |
| 85 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.88174707 |
| 86 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.87672434 |
| 87 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.87448826 |
| 88 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.86092627 |
| 89 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85732746 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.85125190 |
| 91 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.82439994 |
| 92 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.80782447 |
| 93 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.80523699 |
| 94 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 0.80495158 |
| 95 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.79127749 |
| 96 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.78759498 |
| 97 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.78108551 |
| 98 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.77854447 |
| 99 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.76901955 |
| 100 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.75094942 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002166_altered_tumor_susceptibility | 4.48341803 |
| 2 | MP0001348_abnormal_lacrimal_gland | 4.27601250 |
| 3 | MP0000685_abnormal_immune_system | 3.83031368 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.75023574 |
| 5 | MP0010094_abnormal_chromosome_stability | 3.74654527 |
| 6 | MP0002163_abnormal_gland_morphology | 3.65141955 |
| 7 | MP0002006_tumorigenesis | 3.64109720 |
| 8 | MP0003693_abnormal_embryo_hatching | 3.20605596 |
| 9 | MP0004145_abnormal_muscle_electrophysio | 3.19795734 |
| 10 | MP0001800_abnormal_humoral_immune | 2.85381438 |
| 11 | MP0001790_abnormal_immune_system | 2.81379402 |
| 12 | MP0005387_immune_system_phenotype | 2.81379402 |
| 13 | MP0005671_abnormal_response_to | 2.78817912 |
| 14 | MP0002396_abnormal_hematopoietic_system | 2.75922290 |
| 15 | MP0005379_endocrine/exocrine_gland_phen | 2.64202303 |
| 16 | MP0006036_abnormal_mitochondrial_physio | 2.57062468 |
| 17 | MP0003806_abnormal_nucleotide_metabolis | 2.52238947 |
| 18 | MP0003045_fibrosis | 2.43181098 |
| 19 | MP0003786_premature_aging | 2.34306764 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.31925884 |
| 21 | MP0003111_abnormal_nucleus_morphology | 2.28770423 |
| 22 | MP0008058_abnormal_DNA_repair | 2.18905177 |
| 23 | MP0002452_abnormal_antigen_presenting | 2.13761129 |
| 24 | MP0001346_abnormal_lacrimal_gland | 2.04523727 |
| 25 | MP0004957_abnormal_blastocyst_morpholog | 2.03789965 |
| 26 | MP0002148_abnormal_hypersensitivity_rea | 1.95525782 |
| 27 | MP0005310_abnormal_salivary_gland | 1.92067524 |
| 28 | MP0005000_abnormal_immune_tolerance | 1.83621392 |
| 29 | MP0006035_abnormal_mitochondrial_morpho | 1.80183643 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.77296714 |
| 31 | MP0002723_abnormal_immune_serum | 1.73074236 |
| 32 | MP0001819_abnormal_immune_cell | 1.72792259 |
| 33 | MP0002398_abnormal_bone_marrow | 1.69012086 |
| 34 | MP0003077_abnormal_cell_cycle | 1.65802173 |
| 35 | MP0000716_abnormal_immune_system | 1.48331788 |
| 36 | MP0002102_abnormal_ear_morphology | 1.43712244 |
| 37 | MP0005084_abnormal_gallbladder_morpholo | 1.42519787 |
| 38 | MP0003763_abnormal_thymus_physiology | 1.41162771 |
| 39 | MP0003718_maternal_effect | 1.41129577 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.39465667 |
| 41 | MP0008872_abnormal_physiological_respon | 1.34270869 |
| 42 | MP0008007_abnormal_cellular_replicative | 1.32708194 |
| 43 | MP0002429_abnormal_blood_cell | 1.32118215 |
| 44 | MP0009785_altered_susceptibility_to | 1.31417155 |
| 45 | MP0005025_abnormal_response_to | 1.27916397 |
| 46 | MP0003303_peritoneal_inflammation | 1.23658211 |
| 47 | MP0005645_abnormal_hypothalamus_physiol | 1.22687688 |
| 48 | MP0003866_abnormal_defecation | 1.19120542 |
| 49 | MP0003252_abnormal_bile_duct | 1.16100611 |
| 50 | MP0002722_abnormal_immune_system | 1.14023512 |
| 51 | MP0002139_abnormal_hepatobiliary_system | 1.13719976 |
| 52 | MP0004147_increased_porphyrin_level | 1.13000484 |
| 53 | MP0009333_abnormal_splenocyte_physiolog | 1.06639120 |
| 54 | MP0003646_muscle_fatigue | 1.06592182 |
| 55 | MP0002019_abnormal_tumor_incidence | 1.03614296 |
| 56 | MP0000703_abnormal_thymus_morphology | 1.01578023 |
| 57 | MP0005360_urolithiasis | 0.99660706 |
| 58 | MP0002419_abnormal_innate_immunity | 0.99659058 |
| 59 | MP0001845_abnormal_inflammatory_respons | 0.97536956 |
| 60 | MP0005395_other_phenotype | 0.92839928 |
| 61 | MP0010155_abnormal_intestine_physiology | 0.91640851 |
| 62 | MP0005165_increased_susceptibility_to | 0.91591708 |
| 63 | MP0002405_respiratory_system_inflammati | 0.90028596 |
| 64 | MP0010386_abnormal_urinary_bladder | 0.89612273 |
| 65 | MP0002160_abnormal_reproductive_system | 0.89584039 |
| 66 | MP0005389_reproductive_system_phenotype | 0.88857863 |
| 67 | MP0004134_abnormal_chest_morphology | 0.86318298 |
| 68 | MP0005085_abnormal_gallbladder_physiolo | 0.85043081 |
| 69 | MP0005464_abnormal_platelet_physiology | 0.83614428 |
| 70 | MP0008875_abnormal_xenobiotic_pharmacok | 0.83037498 |
| 71 | MP0000749_muscle_degeneration | 0.82655394 |
| 72 | MP0002928_abnormal_bile_duct | 0.79990247 |
| 73 | MP0001873_stomach_inflammation | 0.78666902 |
| 74 | MP0008057_abnormal_DNA_replication | 0.77619880 |
| 75 | MP0000613_abnormal_salivary_gland | 0.74852343 |
| 76 | MP0010234_abnormal_vibrissa_follicle | 0.73827391 |
| 77 | MP0000358_abnormal_cell_content/ | 0.71405688 |
| 78 | MP0002095_abnormal_skin_pigmentation | 0.67992316 |
| 79 | MP0002168_other_aberrant_phenotype | 0.66764669 |
| 80 | MP0002693_abnormal_pancreas_physiology | 0.66567716 |
| 81 | MP0006054_spinal_hemorrhage | 0.66359524 |
| 82 | MP0000371_diluted_coat_color | 0.63359442 |
| 83 | MP0003868_abnormal_feces_composition | 0.62040452 |
| 84 | MP0005075_abnormal_melanosome_morpholog | 0.61263712 |
| 85 | MP0001919_abnormal_reproductive_system | 0.61136603 |
| 86 | MP0001905_abnormal_dopamine_level | 0.60808131 |
| 87 | MP0003950_abnormal_plasma_membrane | 0.60220279 |
| 88 | MP0001661_extended_life_span | 0.58332831 |
| 89 | MP0000465_gastrointestinal_hemorrhage | 0.57876081 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.57784729 |
| 91 | MP0001119_abnormal_female_reproductive | 0.56947488 |
| 92 | MP0006082_CNS_inflammation | 0.56565461 |
| 93 | MP0005408_hypopigmentation | 0.56107444 |
| 94 | MP0000313_abnormal_cell_death | 0.54329277 |
| 95 | MP0005174_abnormal_tail_pigmentation | 0.53329303 |
| 96 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.52741428 |
| 97 | MP0003195_calcinosis | 0.52666855 |
| 98 | MP0003075_altered_response_to | 0.50564842 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.50432107 |
| 100 | MP0008877_abnormal_DNA_methylation | 0.48637253 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Panhypogammaglobulinemia (HP:0003139) | 4.81084174 |
| 2 | Abnormality of the labia minora (HP:0012880) | 4.27743851 |
| 3 | Supernumerary spleens (HP:0009799) | 4.21992879 |
| 4 | Agammaglobulinemia (HP:0004432) | 4.20804552 |
| 5 | Abnormality of the pulmonary veins (HP:0011718) | 4.12915187 |
| 6 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.87741092 |
| 7 | Abnormality of the fetal cardiovascular system (HP:0010948) | 3.72432225 |
| 8 | Abnormal umbilical cord blood vessels (HP:0011403) | 3.72432225 |
| 9 | Single umbilical artery (HP:0001195) | 3.72432225 |
| 10 | Intestinal atresia (HP:0011100) | 3.59079740 |
| 11 | Annular pancreas (HP:0001734) | 3.57784757 |
| 12 | Prostate neoplasm (HP:0100787) | 3.55367748 |
| 13 | Chronic sinusitis (HP:0011109) | 3.53936174 |
| 14 | Increased serum pyruvate (HP:0003542) | 3.45805183 |
| 15 | Gastrointestinal stroma tumor (HP:0100723) | 3.43315392 |
| 16 | Abnormality of the prostate (HP:0008775) | 3.26681085 |
| 17 | Abnormal lung lobation (HP:0002101) | 3.26336906 |
| 18 | Increased CSF lactate (HP:0002490) | 3.26227982 |
| 19 | Hepatocellular necrosis (HP:0001404) | 3.21122306 |
| 20 | Meckel diverticulum (HP:0002245) | 3.18306192 |
| 21 | Colon cancer (HP:0003003) | 3.15780570 |
| 22 | Enlarged penis (HP:0000040) | 3.15607827 |
| 23 | Abnormality of glycolysis (HP:0004366) | 3.15031811 |
| 24 | Hepatic necrosis (HP:0002605) | 3.11938017 |
| 25 | Increased serum lactate (HP:0002151) | 2.96511018 |
| 26 | Mitochondrial inheritance (HP:0001427) | 2.95218053 |
| 27 | Oral leukoplakia (HP:0002745) | 2.93936230 |
| 28 | Papilledema (HP:0001085) | 2.93088021 |
| 29 | Abnormality of the ileum (HP:0001549) | 2.92638839 |
| 30 | Neoplasm of the adrenal cortex (HP:0100641) | 2.91283045 |
| 31 | Neonatal death (HP:0003811) | 2.91221347 |
| 32 | Neoplasm of the adrenal gland (HP:0100631) | 2.86728552 |
| 33 | Abnormality of B cell number (HP:0010975) | 2.74903418 |
| 34 | Acute necrotizing encephalopathy (HP:0006965) | 2.72306817 |
| 35 | Conjunctival hamartoma (HP:0100780) | 2.62856708 |
| 36 | Small intestinal stenosis (HP:0012848) | 2.60798240 |
| 37 | Duodenal stenosis (HP:0100867) | 2.60798240 |
| 38 | Wrist flexion contracture (HP:0001239) | 2.59798167 |
| 39 | Asplenia (HP:0001746) | 2.54828052 |
| 40 | Progressive macrocephaly (HP:0004481) | 2.51192011 |
| 41 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.48595444 |
| 42 | Abnormality of the umbilical cord (HP:0010881) | 2.48557175 |
| 43 | B lymphocytopenia (HP:0010976) | 2.47812346 |
| 44 | Abnormality of T cell physiology (HP:0011840) | 2.46410800 |
| 45 | Verrucae (HP:0200043) | 2.44455411 |
| 46 | Papilloma (HP:0012740) | 2.44455411 |
| 47 | Amaurosis fugax (HP:0100576) | 2.43585195 |
| 48 | Hypoproteinemia (HP:0003075) | 2.39922997 |
| 49 | Clubbing of toes (HP:0100760) | 2.39548772 |
| 50 | Fair hair (HP:0002286) | 2.39387773 |
| 51 | Oligodactyly (hands) (HP:0001180) | 2.36421920 |
| 52 | Facial hemangioma (HP:0000329) | 2.30522095 |
| 53 | Meningitis (HP:0001287) | 2.30434836 |
| 54 | IgA deficiency (HP:0002720) | 2.27070328 |
| 55 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.24762358 |
| 56 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.24529207 |
| 57 | Recurrent bronchitis (HP:0002837) | 2.24151272 |
| 58 | IgG deficiency (HP:0004315) | 2.24076122 |
| 59 | Acute encephalopathy (HP:0006846) | 2.21792897 |
| 60 | Squamous cell carcinoma (HP:0002860) | 2.19957481 |
| 61 | Lymphoma (HP:0002665) | 2.19576680 |
| 62 | Vasculitis (HP:0002633) | 2.18665674 |
| 63 | Recurrent sinusitis (HP:0011108) | 2.18627112 |
| 64 | Chromsome breakage (HP:0040012) | 2.15230805 |
| 65 | Hydroureter (HP:0000072) | 2.14103374 |
| 66 | Hyperglycinemia (HP:0002154) | 2.13838732 |
| 67 | Viral hepatitis (HP:0006562) | 2.10522311 |
| 68 | Cerebral hemorrhage (HP:0001342) | 2.08574932 |
| 69 | Melanoma (HP:0002861) | 2.05179948 |
| 70 | Paralysis (HP:0003470) | 2.02894277 |
| 71 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00604641 |
| 72 | Recurrent viral infections (HP:0004429) | 2.00443319 |
| 73 | Abnormalities of placenta or umbilical cord (HP:0001194) | 1.98547576 |
| 74 | Increased hepatocellular lipid droplets (HP:0006565) | 1.97420140 |
| 75 | Increased density of long bones (HP:0006392) | 1.97319335 |
| 76 | Abnormality of the duodenum (HP:0002246) | 1.96078432 |
| 77 | Respiratory failure (HP:0002878) | 1.95352154 |
| 78 | Thyroiditis (HP:0100646) | 1.95299921 |
| 79 | Premature loss of primary teeth (HP:0006323) | 1.94584469 |
| 80 | Lymphopenia (HP:0001888) | 1.93942789 |
| 81 | Neutropenia (HP:0001875) | 1.93802097 |
| 82 | IgM deficiency (HP:0002850) | 1.91886468 |
| 83 | Reduced antithrombin III activity (HP:0001976) | 1.91432457 |
| 84 | Entropion (HP:0000621) | 1.88422380 |
| 85 | Stillbirth (HP:0003826) | 1.87106462 |
| 86 | Abnormality of chromosome stability (HP:0003220) | 1.85648773 |
| 87 | Osteomyelitis (HP:0002754) | 1.83240767 |
| 88 | Abnormality of the renal collecting system (HP:0004742) | 1.82841693 |
| 89 | Basal cell carcinoma (HP:0002671) | 1.82625308 |
| 90 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.81856711 |
| 91 | Exertional dyspnea (HP:0002875) | 1.81183832 |
| 92 | Chronic otitis media (HP:0000389) | 1.80969808 |
| 93 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.79693463 |
| 94 | Hypoplastic left heart (HP:0004383) | 1.78627877 |
| 95 | Limb hypertonia (HP:0002509) | 1.78410629 |
| 96 | Hamartoma of the eye (HP:0010568) | 1.77327819 |
| 97 | Lipid accumulation in hepatocytes (HP:0006561) | 1.77157355 |
| 98 | Cerebral edema (HP:0002181) | 1.76245025 |
| 99 | Renal Fanconi syndrome (HP:0001994) | 1.75808359 |
| 100 | Chest pain (HP:0100749) | 1.75507165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 6.08461273 |
| 2 | EIF2AK3 | 4.57269591 |
| 3 | TAF1 | 4.46661037 |
| 4 | SMG1 | 4.28906760 |
| 5 | BUB1 | 3.84265349 |
| 6 | EIF2AK1 | 3.67665759 |
| 7 | MST4 | 3.14511847 |
| 8 | VRK1 | 3.00069227 |
| 9 | CCNB1 | 2.88475505 |
| 10 | NUAK1 | 2.55695465 |
| 11 | ZAK | 2.40139032 |
| 12 | PLK2 | 2.16563756 |
| 13 | TLK1 | 2.05823790 |
| 14 | RIPK4 | 1.96778722 |
| 15 | PLK3 | 1.92771381 |
| 16 | TAOK3 | 1.92085432 |
| 17 | STK38L | 1.83838292 |
| 18 | STK24 | 1.82040457 |
| 19 | MAPKAPK5 | 1.74021120 |
| 20 | NEK1 | 1.70509646 |
| 21 | EIF2AK2 | 1.62191707 |
| 22 | BMPR2 | 1.61861730 |
| 23 | NEK9 | 1.44386973 |
| 24 | MKNK2 | 1.33181841 |
| 25 | GRK1 | 1.31570871 |
| 26 | GRK5 | 1.29822405 |
| 27 | DAPK1 | 1.23476722 |
| 28 | SYK | 1.18840799 |
| 29 | NME1 | 1.12997491 |
| 30 | OXSR1 | 1.10341056 |
| 31 | BMPR1B | 1.09675565 |
| 32 | FRK | 1.09207593 |
| 33 | MELK | 1.08356383 |
| 34 | DAPK3 | 1.08143241 |
| 35 | WEE1 | 1.00207959 |
| 36 | PLK4 | 0.94697536 |
| 37 | TSSK6 | 0.90154257 |
| 38 | TTK | 0.89154977 |
| 39 | MKNK1 | 0.87774400 |
| 40 | MAP4K1 | 0.87172840 |
| 41 | STK39 | 0.83143580 |
| 42 | IKBKB | 0.80020656 |
| 43 | BLK | 0.76533705 |
| 44 | STK3 | 0.74245690 |
| 45 | ALK | 0.72182545 |
| 46 | STK4 | 0.67215520 |
| 47 | ATR | 0.66576868 |
| 48 | STK16 | 0.65011101 |
| 49 | AURKB | 0.63564401 |
| 50 | CSNK1G3 | 0.62809290 |
| 51 | CDC7 | 0.59886226 |
| 52 | LYN | 0.58368443 |
| 53 | PRKCI | 0.55363826 |
| 54 | CDK8 | 0.55192191 |
| 55 | FES | 0.54435644 |
| 56 | KIT | 0.54109957 |
| 57 | PLK1 | 0.53726268 |
| 58 | TYK2 | 0.50656154 |
| 59 | CSNK1A1L | 0.49463326 |
| 60 | JAK3 | 0.47958939 |
| 61 | ITK | 0.43301020 |
| 62 | CSNK1G2 | 0.42694858 |
| 63 | CSF1R | 0.42339964 |
| 64 | CDK9 | 0.41935119 |
| 65 | PRKCQ | 0.41598684 |
| 66 | TEC | 0.38822270 |
| 67 | INSRR | 0.38815035 |
| 68 | AURKA | 0.35793946 |
| 69 | BTK | 0.35450942 |
| 70 | ADRBK2 | 0.34044427 |
| 71 | PHKG2 | 0.32101498 |
| 72 | PHKG1 | 0.32101498 |
| 73 | MAPK4 | 0.31951315 |
| 74 | CSNK1G1 | 0.31109885 |
| 75 | CHEK2 | 0.30828476 |
| 76 | HIPK2 | 0.30696107 |
| 77 | CSK | 0.30548414 |
| 78 | PASK | 0.30021036 |
| 79 | BCR | 0.29677692 |
| 80 | CSNK2A1 | 0.26796390 |
| 81 | JAK1 | 0.25891551 |
| 82 | STK10 | 0.25648365 |
| 83 | MAP3K8 | 0.25492425 |
| 84 | ATM | 0.25303300 |
| 85 | PRKCD | 0.24116948 |
| 86 | NEK2 | 0.24022461 |
| 87 | TNIK | 0.23877573 |
| 88 | CDK7 | 0.22309473 |
| 89 | CSNK2A2 | 0.21485285 |
| 90 | GRK6 | 0.20654762 |
| 91 | DYRK2 | 0.20612733 |
| 92 | NME2 | 0.20214514 |
| 93 | ACVR1B | 0.18892450 |
| 94 | CHEK1 | 0.17273425 |
| 95 | PIM1 | 0.15952684 |
| 96 | LCK | 0.15752314 |
| 97 | MAP3K5 | 0.15735083 |
| 98 | TBK1 | 0.14977362 |
| 99 | HCK | 0.14758356 |
| 100 | RPS6KA4 | 0.14723231 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 4.42633330 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.69686133 |
| 3 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 3.54582122 |
| 4 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.37485221 |
| 5 | Asthma_Homo sapiens_hsa05310 | 3.15188989 |
| 6 | Allograft rejection_Homo sapiens_hsa05330 | 3.11140411 |
| 7 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.92046350 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.76078589 |
| 9 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.72393950 |
| 10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.69315037 |
| 11 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 2.61373433 |
| 12 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.42251723 |
| 13 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.30622496 |
| 14 | DNA replication_Homo sapiens_hsa03030 | 2.27069226 |
| 15 | Mismatch repair_Homo sapiens_hsa03430 | 2.23884817 |
| 16 | Protein export_Homo sapiens_hsa03060 | 2.23379969 |
| 17 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.14906304 |
| 18 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.03960357 |
| 19 | Homologous recombination_Homo sapiens_hsa03440 | 1.90694680 |
| 20 | Viral myocarditis_Homo sapiens_hsa05416 | 1.83868206 |
| 21 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.78332128 |
| 22 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.66075987 |
| 23 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.62800358 |
| 24 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.62463940 |
| 25 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.49144231 |
| 26 | RNA degradation_Homo sapiens_hsa03018 | 1.47749383 |
| 27 | Base excision repair_Homo sapiens_hsa03410 | 1.42556609 |
| 28 | Parkinsons disease_Homo sapiens_hsa05012 | 1.36802145 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.33301660 |
| 30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.31691396 |
| 31 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.30375597 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.27293618 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.26703399 |
| 34 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.12099037 |
| 35 | Ribosome_Homo sapiens_hsa03010 | 1.11226592 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.04318195 |
| 37 | RNA polymerase_Homo sapiens_hsa03020 | 1.03547325 |
| 38 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.02370260 |
| 39 | Carbon metabolism_Homo sapiens_hsa01200 | 1.00875592 |
| 40 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.00841496 |
| 41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.98207493 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 0.92865427 |
| 43 | Leishmaniasis_Homo sapiens_hsa05140 | 0.87988312 |
| 44 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.87711085 |
| 45 | RNA transport_Homo sapiens_hsa03013 | 0.87295354 |
| 46 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.86127994 |
| 47 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.84291837 |
| 48 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.83375545 |
| 49 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.81900509 |
| 50 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.77594280 |
| 51 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.77558343 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.77119435 |
| 53 | Cell cycle_Homo sapiens_hsa04110 | 0.72554882 |
| 54 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.72288284 |
| 55 | Alzheimers disease_Homo sapiens_hsa05010 | 0.72139590 |
| 56 | Huntingtons disease_Homo sapiens_hsa05016 | 0.71801179 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.67879560 |
| 58 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.66584283 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.65548676 |
| 60 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.64293826 |
| 61 | Purine metabolism_Homo sapiens_hsa00230 | 0.62976885 |
| 62 | Spliceosome_Homo sapiens_hsa03040 | 0.62940679 |
| 63 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57982393 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.55961676 |
| 65 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.55747758 |
| 66 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.53500420 |
| 67 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.50468890 |
| 68 | Measles_Homo sapiens_hsa05162 | 0.49408763 |
| 69 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49072969 |
| 70 | Alcoholism_Homo sapiens_hsa05034 | 0.45417914 |
| 71 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.43572526 |
| 72 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.40844409 |
| 73 | Tuberculosis_Homo sapiens_hsa05152 | 0.38413131 |
| 74 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.38196431 |
| 75 | Peroxisome_Homo sapiens_hsa04146 | 0.36368445 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.33745023 |
| 77 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33259326 |
| 78 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30290087 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.29904880 |
| 80 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.27744985 |
| 81 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.27343966 |
| 82 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.24275957 |
| 83 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.24244099 |
| 84 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.22775116 |
| 85 | Metabolic pathways_Homo sapiens_hsa01100 | 0.22730321 |
| 86 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.22655087 |
| 87 | Phagosome_Homo sapiens_hsa04145 | 0.21790958 |
| 88 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.20713703 |
| 89 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.19110634 |
| 90 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.18302485 |
| 91 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.17889082 |
| 92 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.10733820 |
| 93 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.10461336 |
| 94 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.10356561 |
| 95 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.09337735 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.08523451 |
| 97 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.08333311 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.04135052 |
| 99 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.03706395 |
| 100 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.02566849 |

